King Abdul-Aziz University
Also known as: Assistant Professor, Department of Oral and Maxillofacial Prosthodontics, King Abdul-Aziz University, Jeddah, Saudi Arabia | Assistant Professor, Department of Pediatric Dentistry King Abdulaziz University | Assistant Professor, Department of Restorative Dentistry, King Abdul-Aziz University, Jeddah, Saudi Arabia | Center of Excellence for Osteoporosis Research and Faculty of Medicine, King Abdulaziz University | Center of Excellence for Osteoporosis Research, and Faculty of Medicine, King Abdulaziz University | Chair for Biomarkers of Chronic Diseases | Heba sabbagh | KAIMRC, King Saud bin Abdulaziz University for Health Sciences, Pharmaceutical Care Department, King Khalid Hospital, Ministry of National Guard Health Affairs, Jeddah, Saudi Arabia, Harvard T. H. Chan School of Public Health, Boston, MA, USA | King Abdelaziz University | King AbdulAziz City for Science and Technology | King Abdulaziz Medical City | King Abdul Aziz Medical City for National Guard | King Abdulaziz Medical City, National Guard / Riyadh-Saudi Arabia | King Abdulaziz Medical city , WR | King Abdulaziz National Guard Hospital, Riyadh | King Abdulaziz National Guard Hospital, Riyadh, Kingdom of Saudi Arabia | King Abdul Aziz Specialist Hospital | King Abdulaziz University | King Abdulaziz University, Faculty of Dentistry | King Abdulaziz University, jeddah, Saudi Arabia | King Abdullah Medical City | King Saud Bin Abdulaziz University for Health Sciences
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2007Last known activity
Nov 24, 2025
Timeline
2000s
- Jan 1, 2005
King Abdul-Aziz University— Founded
Drugs by trial phase (76 distinct, 64 trials)
Phase 4 (27 own, 0 via acquisition)
Phase 3 (19 own, 0 via acquisition)
Phase 2 (13 own, 0 via acquisition)
Phase 1 (5 own, 0 via acquisition)
Other trials (12 own, 0 via acquisition)
Indications
Studied for
- Acidosis
- Amino Acid Metabolism, Inborn Errors
- Asthma
- Calculi
- Carcinoma, Non-Small-Cell Lung
- Colorectal Neoplasms
- Coronavirus Infections
- Critical Illness
- Crohn Disease
- Dental Caries
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Genital Neoplasms, Female
- Glucose Metabolism Disorders
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis B, Chronic
- Hepatitis C
- Hepatitis C, Chronic
- Hepatitis, Chronic
- Hyaline Membrane Disease
- Inflammation
- Irritable Bowel Syndrome
- Kidney Calculi
- Labor Pain
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Lung Neoplasms
- Metabolic Diseases
- Nephrolithiasis
- Pancreatic Neoplasms
- Pneumonia
- Pneumonia, Ventilator-Associated
- Polycystic Ovary Syndrome
- Propionic Acidemia
- Psychomotor Agitation
- Rectal Neoplasms
- Respiratory Distress Syndrome
- Respiratory Distress Syndrome, Newborn
- Respiratory Insufficiency
- Restless Legs Syndrome
- Shock, Septic
- Syndrome
- Ureteral Calculi
- Ureterolithiasis
- Vitamin D Deficiency
Recent trials (50)
- NCT07280507Lead sponsorEarly Phase 1Nov 24, 2025
- NCT07280507Sponsor investigatorEarly Phase 1Nov 24, 2025
- NCT07013071Lead sponsorPhase 4Feb 10, 2024
- NCT07013071Sponsor investigatorPhase 4Feb 10, 2024
- NCT06953440Lead sponsorPhase 4Feb 1, 2024
- NCT06953440Sponsor investigatorPhase 4Feb 1, 2024
- NCT06151015CollaboratorN/AJan 1, 2024
- NCT06699199Lead sponsorPhase 4Nov 1, 2023
- NCT06699199Sponsor investigatorPhase 4Nov 1, 2023
- NCT05350124Reponsible party - principal investigatorPhase 3Nov 30, 2022
- NCT05350124Lead sponsorPhase 3Nov 30, 2022
- NCT05497895Reponsible party - principal investigatorEarly Phase 1Sep 30, 2022
- NCT05497895Lead sponsorEarly Phase 1Sep 30, 2022
- NCT05497895Sponsor investigatorEarly Phase 1Sep 30, 2022
- NCT04941131Lead sponsorPhase 4Jul 31, 2021
Details
- Founded
- Riyadh, SA Jan 1, 2005
- Last known activity
- Nov 24, 2025
Notes
--- Pre-folding founded info: None None None None None ---